%20(2).png)
Yale's EGFR/HER2 Vaccine - Prof. Mark Mamula
- CCRA
- Oct 10, 2020
- 1 min read
Updated: Aug 4
On Oct 3, 2020 CCRA hosted a scientific seminar by Professor Mark Mamula where he described his team's work on EGFR-peptide canine cancer vaccine. A summary of the work is described in a previous blog.
Here, we provide
the recording of the seminar,
the slides from the seminar, and
the story of Ranger - a golden retriever whose pulmonary metastasis disappeared after receiving vaccine injections.
According to Prof. Mamula, a subset of dogs (5-6 dogs) with osteosarcomain his study have experienced resolving of pulmonary metastasis. His data will soon be published in a peer-reviewed journal.
Lecture and Q&A - Professor Mark Mamula
Lecture slides
Ranger's story
Ranger is a golden retriever who was diagnosed with osteosarcoma in spring of 2019. After amputation surgery and chemotherapy treatment, he developed pulmonary metastasis by fall of 2019. His tumor disappeared after the vaccine treatment, as described by Ranger's dad, Rick Kneisel.
Check Out Other Articles and Videos
If you have questions, feel free to email us at info@ccralliance. We’ll respond as soon as we can!
Canine Cancer Alliance is a non-profit organization dedicated to supporting research for canine cancer cures.
All information on the Canine Cancer Alliance website is for educational purposes only. It is not intended to replace professional veterinary advice.
Always consult your veterinarian with any questions regarding your pet’s health and medical condition.
The story of Ranger and the other dogs experiencing resolution of pulmonary metastasis is truly remarkable and offers immense hope for canine cancer patients. It's fascinating how Professor Mamula's team is developing such targeted approaches, suggesting a new front in the fight against aggressive cancers. I'm keen to see the published data, as breakthrough science often feels like watching complex sz games unfold, with each move bringing us closer to a solution.